Preliminary in vitro evaluation of the anti-proliferative activity of guanylhydrazone derivatives. 2016

Paulo H B França, and Edeildo F Da Silva-Júnior, and Pedro G V Aquino, and Antônio E G Santana, and Jamylle N S Ferro, and Emiliano De Oliveira Barreto, and Cláudia Do Ó Pessoa, and Assuero Silva Meira, and Thiago M De Aquino, and Magna S Alexandre-Moreira, and Martine Schmitt, and João X De Araújo-Júnior

Guanylhydrazones have shown promising antitumor activity in preclinical tumor models in several studies. In this study, we aimed at evaluating the cytotoxic effect of a series of synthetic guanylhydrazones. Different human tumor cell lines, by including HCT-8 (colon carcinoma), MDA-MB-435 (melanoma) and SF-295 (glioblastoma) were continuous exposed to guanylhydrazone derivatives for 72 hours and growth inhibition of tumor cell lines and macrophages J774 was measured using tetrazolium salt (MTT) assay. Compounds 7, 11, 16 and 17 showed strong cytotoxic activity with IC50 values lower than 10 μmol L(-1) against four tumor cell lines. Among them, 7 was less toxic to non-tumor cells. Finally, obtained data suggest that guanylhydrazones may be regarded as potential lead compounds for the design of novel anticancer agents.

UI MeSH Term Description Entries
D003603 Cytotoxins Substances that are toxic to cells; they may be involved in immunity or may be contained in venoms. These are distinguished from CYTOSTATIC AGENTS in degree of effect. Some of them are used as CYTOTOXIC ANTIBIOTICS. The mechanism of action of many of these are as ALKYLATING AGENTS or MITOSIS MODULATORS. Cytolysins,Cytotoxic Agent,Cytotoxic Agents,Cytotoxin,Agent, Cytotoxic
D004354 Drug Screening Assays, Antitumor Methods of investigating the effectiveness of anticancer cytotoxic drugs and biologic inhibitors. These include in vitro cell-kill models and cytostatic dye exclusion tests as well as in vivo measurement of tumor growth parameters in laboratory animals. Anticancer Drug Sensitivity Tests,Antitumor Drug Screens,Cancer Drug Tests,Drug Screening Tests, Tumor-Specific,Dye Exclusion Assays, Antitumor,Anti-Cancer Drug Screens,Antitumor Drug Screening Assays,Tumor-Specific Drug Screening Tests,Anti Cancer Drug Screens,Anti-Cancer Drug Screen,Antitumor Drug Screen,Cancer Drug Test,Drug Screen, Anti-Cancer,Drug Screen, Antitumor,Drug Screening Tests, Tumor Specific,Drug Screens, Anti-Cancer,Drug Screens, Antitumor,Drug Test, Cancer,Drug Tests, Cancer,Screen, Anti-Cancer Drug,Screen, Antitumor Drug,Screens, Anti-Cancer Drug,Screens, Antitumor Drug,Test, Cancer Drug,Tests, Cancer Drug,Tumor Specific Drug Screening Tests
D006801 Humans Members of the species Homo sapiens. Homo sapiens,Man (Taxonomy),Human,Man, Modern,Modern Man
D006835 Hydrazones Compounds of the general formula R:N.NR2, as resulting from the action of hydrazines with aldehydes or ketones. (Grant & Hackh's Chemical Dictionary, 5th ed) Hydrazone
D000970 Antineoplastic Agents Substances that inhibit or prevent the proliferation of NEOPLASMS. Anticancer Agent,Antineoplastic,Antineoplastic Agent,Antineoplastic Drug,Antitumor Agent,Antitumor Drug,Cancer Chemotherapy Agent,Cancer Chemotherapy Drug,Anticancer Agents,Antineoplastic Drugs,Antineoplastics,Antitumor Agents,Antitumor Drugs,Cancer Chemotherapy Agents,Cancer Chemotherapy Drugs,Chemotherapeutic Anticancer Agents,Chemotherapeutic Anticancer Drug,Agent, Anticancer,Agent, Antineoplastic,Agent, Antitumor,Agent, Cancer Chemotherapy,Agents, Anticancer,Agents, Antineoplastic,Agents, Antitumor,Agents, Cancer Chemotherapy,Agents, Chemotherapeutic Anticancer,Chemotherapy Agent, Cancer,Chemotherapy Agents, Cancer,Chemotherapy Drug, Cancer,Chemotherapy Drugs, Cancer,Drug, Antineoplastic,Drug, Antitumor,Drug, Cancer Chemotherapy,Drug, Chemotherapeutic Anticancer,Drugs, Antineoplastic,Drugs, Antitumor,Drugs, Cancer Chemotherapy
D045744 Cell Line, Tumor A cell line derived from cultured tumor cells. Tumor Cell Line,Cell Lines, Tumor,Line, Tumor Cell,Lines, Tumor Cell,Tumor Cell Lines
D049109 Cell Proliferation All of the processes involved in increasing CELL NUMBER including CELL DIVISION. Cell Growth in Number,Cellular Proliferation,Cell Multiplication,Cell Number Growth,Growth, Cell Number,Multiplication, Cell,Number Growth, Cell,Proliferation, Cell,Proliferation, Cellular

Related Publications

Paulo H B França, and Edeildo F Da Silva-Júnior, and Pedro G V Aquino, and Antônio E G Santana, and Jamylle N S Ferro, and Emiliano De Oliveira Barreto, and Cláudia Do Ó Pessoa, and Assuero Silva Meira, and Thiago M De Aquino, and Magna S Alexandre-Moreira, and Martine Schmitt, and João X De Araújo-Júnior
June 1965, Bollettino della Societa italiana di biologia sperimentale,
Paulo H B França, and Edeildo F Da Silva-Júnior, and Pedro G V Aquino, and Antônio E G Santana, and Jamylle N S Ferro, and Emiliano De Oliveira Barreto, and Cláudia Do Ó Pessoa, and Assuero Silva Meira, and Thiago M De Aquino, and Magna S Alexandre-Moreira, and Martine Schmitt, and João X De Araújo-Júnior
January 2020, Bioorganic & medicinal chemistry letters,
Paulo H B França, and Edeildo F Da Silva-Júnior, and Pedro G V Aquino, and Antônio E G Santana, and Jamylle N S Ferro, and Emiliano De Oliveira Barreto, and Cláudia Do Ó Pessoa, and Assuero Silva Meira, and Thiago M De Aquino, and Magna S Alexandre-Moreira, and Martine Schmitt, and João X De Araújo-Júnior
May 2016, European journal of medicinal chemistry,
Paulo H B França, and Edeildo F Da Silva-Júnior, and Pedro G V Aquino, and Antônio E G Santana, and Jamylle N S Ferro, and Emiliano De Oliveira Barreto, and Cláudia Do Ó Pessoa, and Assuero Silva Meira, and Thiago M De Aquino, and Magna S Alexandre-Moreira, and Martine Schmitt, and João X De Araújo-Júnior
August 2019, Bioorganic & medicinal chemistry,
Paulo H B França, and Edeildo F Da Silva-Júnior, and Pedro G V Aquino, and Antônio E G Santana, and Jamylle N S Ferro, and Emiliano De Oliveira Barreto, and Cláudia Do Ó Pessoa, and Assuero Silva Meira, and Thiago M De Aquino, and Magna S Alexandre-Moreira, and Martine Schmitt, and João X De Araújo-Júnior
July 2005, Bioorganic & medicinal chemistry,
Paulo H B França, and Edeildo F Da Silva-Júnior, and Pedro G V Aquino, and Antônio E G Santana, and Jamylle N S Ferro, and Emiliano De Oliveira Barreto, and Cláudia Do Ó Pessoa, and Assuero Silva Meira, and Thiago M De Aquino, and Magna S Alexandre-Moreira, and Martine Schmitt, and João X De Araújo-Júnior
October 2016, Molecules (Basel, Switzerland),
Paulo H B França, and Edeildo F Da Silva-Júnior, and Pedro G V Aquino, and Antônio E G Santana, and Jamylle N S Ferro, and Emiliano De Oliveira Barreto, and Cláudia Do Ó Pessoa, and Assuero Silva Meira, and Thiago M De Aquino, and Magna S Alexandre-Moreira, and Martine Schmitt, and João X De Araújo-Júnior
May 2012, European journal of medicinal chemistry,
Paulo H B França, and Edeildo F Da Silva-Júnior, and Pedro G V Aquino, and Antônio E G Santana, and Jamylle N S Ferro, and Emiliano De Oliveira Barreto, and Cláudia Do Ó Pessoa, and Assuero Silva Meira, and Thiago M De Aquino, and Magna S Alexandre-Moreira, and Martine Schmitt, and João X De Araújo-Júnior
August 2020, Data in brief,
Paulo H B França, and Edeildo F Da Silva-Júnior, and Pedro G V Aquino, and Antônio E G Santana, and Jamylle N S Ferro, and Emiliano De Oliveira Barreto, and Cláudia Do Ó Pessoa, and Assuero Silva Meira, and Thiago M De Aquino, and Magna S Alexandre-Moreira, and Martine Schmitt, and João X De Araújo-Júnior
January 2003, Arzneimittel-Forschung,
Paulo H B França, and Edeildo F Da Silva-Júnior, and Pedro G V Aquino, and Antônio E G Santana, and Jamylle N S Ferro, and Emiliano De Oliveira Barreto, and Cláudia Do Ó Pessoa, and Assuero Silva Meira, and Thiago M De Aquino, and Magna S Alexandre-Moreira, and Martine Schmitt, and João X De Araújo-Júnior
October 2015, Bioorganic & medicinal chemistry letters,
Copied contents to your clipboard!